Country: Իսպանիա
language: անգլերեն
source: HMA (Heads of Medicines Agencies)
clindamycin chlorohydrate 25 %
Chanelle Pharmaceutical Manufacturing Ltd
QJ01FF01
Oral solution
clindamycin
Cats, Dogs
2012-02-23
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Clindaseptin 25mg/ml Oral Solution for Cats and Dogs. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains: ACTIVE SUBSTANCE: Clindamycin 25 mg (as Clindamycin hydrochloride 27.15 mg ) EXCIPIENTS Ethanol 96 % 90.56 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral solution. Clear, colourless solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats and dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Cats: For the treatment of infected wounds and abscesses caused by clindamycin-sensitive species of _Staphylococcus_ _spp_ and _Streptococcus spp_. Dogs: For the treatment of infected wounds, abscesses and oral cavity/dental infections caused by or associated with clindamycin-sensitive species of _Staphylococcus spp_, _Streptococcus spp_, _Bacteroides spp_, _Fusobacterium necrophorum_, _Clostridium perfringens _ Adjunctive treatment of mechanical or surgical periodontal therapy in the treatment of infections of the gingival and periodontal tissues For the treatment of osteomyelitis caused by _Staphylococcus aureus_ 4.3 CONTRAINDICATIONS Do not use in rabbits, hamsters, guinea pigs, chinchillas, horses or ruminants because ingestion of clindamycin by these species may cause severe gastrointestinal disorders. Do not use in cases of hypersensitivity to either clindamycin or lincomycin, or to any of the excipients. 4.4 SPECIAL WARNINGSNone. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIM read_full_document